← USPTO Patent Applications

ENGINEERED IMMUNE CELLS

Application US20260083845A1 Kind: A1 Mar 26, 2026

Assignee

Cellicure, Inc.

Inventors

Minggang Zhang, Belle X. Wang, Yongmei Li, Nathan X. Li, Qisheng Li

Abstract

The present application relates to chimeric antigen receptors (CARs), engineered immune cells (e.g., NK cells, NKT cells, and T cells), and methods of use thereof. The CARs provided herein can enhance the killing activities of the engineered NK cells.

CPC Classifications

A61K 40/15 A61K 40/31 A61K 40/4211 A61P 35/00 C07K 14/7051 C07K 16/2803 A61K 2239/22 C07K 2317/622

Filing Date

2023-09-22

Application No.

19112644